哮喘急性发作倾向表型及发作频率预测生物标志物的证据
基于严重哮喘研究项目-3中406例成人哮喘患者3年急性发作数据的前瞻性分析,确认了急性发作倾向哮喘(EPA)表型的存在,其特征为代谢功能障碍相关表现;血浆IL-6(而非血嗜酸性粒细胞)与EPA显著相关,IL-6和嗜酸性粒细胞均可预测整体样本的急性发作。
要点
- 21%的成人哮喘患者每年至少发作1次,构成急性发作倾向哮喘(EPA)表型。
- EPA与较低FEV1及肥胖、高血压、糖尿病患病率较高相关。
- 基线IL-6每升高1 pg/μl,急性发作发生率比增加10%。
核心结论
- 纵向分析确认了以代谢功能障碍为特征的急性发作倾向哮喘(EPA)表型。
- 血浆IL-6(而非嗜酸性粒细胞)与EPA显著相关,IL-6和嗜酸性粒细胞均可预测整体样本的急性发作。
研究设计与样本
- 分析严重哮喘研究项目-3中406例成人哮喘患者3年急性发作数据的前瞻性研究。
- 采用转移模型评估第3年急性发作的非条件概率和条件概率。
- 采用二项回归模型评估嗜酸性粒细胞和IL-6作为预测生物标志物。
主要发现
- 第3年急性发作的非条件概率为40%,第2年有发作时条件概率增至63%,第1年和第2年均发作时增至82%。
- 第1年和第2年均无发作时第3年发作概率为13%。
- 与发作抵抗型哮喘相比,EPA以较低FEV1及较高肥胖、高血压和糖尿病患病率为特征。
- EPA中高血浆IL-6常见,基线IL-6每升高1 pg/μl,急性发作发生率比增加10%;基线嗜酸性粒细胞每升高100 cell/μl,发生率比增加9%。
临床怎么用
- 对成人哮喘患者可检测基线血浆IL-6和血嗜酸性粒细胞以辅助预测未来急性发作风险。
- 关注具有肥胖、高血压、糖尿病等代谢功能障碍特征的哮喘患者,其可能属于EPA表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Cross-sectional studies suggest an exacerbation-prone asthma (EPA) phenotype and the utility of blood eosinophils and plasma IL-6 as predictive biomarkers.Objectives: To prospectively test for EPA phenotype and utility of baseline blood measures of eosinophils and IL-6 as predictive biomarkers.Methods: Three-year asthma exacerbation data were analyzed in 406 adults in the Severe Asthma Research Program-3. Transition models were used to assess uninformed and informed probabilities of exacerbation in year 3. Binomial regression models were used to assess eosinophils and IL-6 as predictive biomarkers.Measurements and Main Results: Eighty-three participants (21%) had ≥1 exacerbation in each year (EPA) and 168 participants (41%) had no exacerbation in any year (exacerbation-resistant asthma). The uninformed probability of an exacerbation in Year 3 was 40%, but the informed probability increased to 63% with an exacerbation in Year 2 and 82% with an exacerbation in Years 1 and 2. The probability of a Year 3 exacerbation with no Year 1 or 2 exacerbations was 13%. Compared with exacerbation-resistant asthma, EPA was characterized by lower FEV1 and a higher prevalence of obesity, hypertension, and diabetes. High-plasma IL-6 occurred in EPA, and the incident rate ratio for exacerbation increased 10% for each 1-pg/μl increase in baseline IL-6 level. Although high blood eosinophils did not occur in EPA, the incident rate ratio for exacerbations increased 9% for each 100-cell/μl increase in baseline eosinophil number.Conclusions: Longitudinal analysis confirms an EPA phenotype characterized by features of metabolic dysfunction. Blood measures of IL-6, but not eosinophils, were significantly associated with EPA, and IL-6 and eosinophils predicted exacerbations in the sample as a whole.
引用
- Peters MC, Mauger D, Ross KR, et al. Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency. Am J Respir Crit Care Med. 2020. PMID: 32479111. doi:10.1164/rccm.201909-1813OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。